Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arrhythmia Therapy
New arrhythmia therapy research has been reported by scientists at National Taiwan University, Institute of Pharmacology
March 2nd, 2007
Fresh data on arrhythmia are presented in the report "In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Resveratrol (trans-3, 4', 5-trihydroxystilbene), a natural antioxidant derived from grapes, has beneficial effects against coronary heart disease. Its electrophysiological characteristics for antiarrhythmic efficacy are largely unknown; thus, this study aims to explore the resveratrol's antiarrhythmic effects and conduction system in isolated hearts as well as its electrophysiological effects on cardiac myocytes," scientists in Taipei, Taiwan report. "In the experiment, resveratrol suppressed the...
Source: Drug Week (2007-03-02)
|
